2023 annual financial data
CNS Pharmaceuticals 2023 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -18,865,108 USD and net income was -18,851,226 USD.
Operating cash flow was -14,140,031 USD.
Get free CNS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -18,865,108 USD
- Net income
- -18,851,226 USD
- Operating cash flow
- -14,140,031 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all CNS Pharmaceuticals financial years